Vertex Pharmaceuticals (VRTX) Operating Leases (2018 - 2026)

Vertex Pharmaceuticals (VRTX) posted quarterly Operating Leases of $2.0 billion for Q1 2026, up 29.19% year-over-year from $1.5 billion in Q1 2025, and up 7.58% on a QoQ basis from $1.8 billion in Q4 2025.

Vertex Pharmaceuticals (VRTX) Operating Leases (2018 - 2026) Analysis & Trends

Vertex Pharmaceuticals (VRTX) has reported Operating Leases for 9 consecutive years, with $2.0 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Operating Leases rose 29.19% year-over-year to $2.0 billion; the TTM figure through Mar 2026 stood at $2.0 billion (up 29.19% YoY), while the FY2025 annual figure was $1.8 billion, up 19.56% from the prior year.
  • Operating Leases came in at $2.0 billion for Q1 2026 at Vertex Pharmaceuticals, up from $1.8 billion in the prior quarter.
  • The five-year high for Operating Leases was $2.0 billion in Q1 2026, with the low at $348.6 million in Q4 2023.
  • Average Operating Leases over 5 years is $929.6 million, with a median of $428.1 million recorded in 2022.
  • Across the five-year window, Operating Leases decreased 18.57% in 2023 and soared 348.34% in 2024, its largest moves.
  • Year by year, Operating Leases stood at $428.1 million in 2022, then dropped by 18.57% to $348.6 million in 2023, then soared by 343.03% to $1.5 billion in 2024, then increased by 19.56% to $1.8 billion in 2025, then advanced by 7.58% to $2.0 billion in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $2.0 billion, $1.8 billion, and $1.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn -
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn -
10 Moderna 28.64 Bn 23.43 Bn -566.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.99 Bn
Dec 31, 2025 1.85 Bn
Sep 30, 2025 1.83 Bn
Jun 30, 2025 1.53 Bn
Mar 31, 2025 1.54 Bn
Dec 31, 2024 1.54 Bn
Sep 30, 2024 1.59 Bn
Jun 30, 2024 586.80 Mn
Mar 31, 2024 359.80 Mn
Dec 31, 2023 348.60 Mn
Sep 30, 2023 354.40 Mn
Jun 30, 2023 363.50 Mn
Mar 31, 2023 371.60 Mn
Dec 31, 2022 428.10 Mn
Sep 30, 2022 382.30 Mn
Jun 30, 2022 365.00 Mn
Mar 31, 2022 377.00 Mn
Dec 31, 2021 410.70 Mn
Sep 30, 2021 363.55 Mn
Jun 30, 2021 368.92 Mn